BACKGROUND: Peroxisome proliferator-activated receptor-alpha (PPARA) regulates the expression of genes involved in lipid metabolism. The binding of polyunsaturated fatty acids (PUFAs) to PPARA results in rapid changes in the expression of genes involved in lipid oxidation, with long-chain n-3 fatty acids being potent activators of PPARA. OBJECTIVE: We evaluated the potential effect modification of PPARA genetic variation on the association between PUFA intake, specifically n-6 and long-chain n-3 fatty acid intakes, and multiple lipid measures in the large biethnic Atherosclerosis Risk in Communities (ARIC) Study. DESIGN: Study participants (10 134 whites and 3480 African Americans) were selected from the ARIC Study--a prospective investigation of atherosclerosis and its clinical sequelae. Multiple linear regression models were used to assess the relation between PPARA genotypes, as well as dietary fatty acid intake, and baseline lipid measures. PPARA-specific effects of variation were assessed by including genotype-by-fatty acid interaction terms in each statistical model. RESULTS: PPARA genotype frequencies were significantly different between whites and African Americans. No significant associations between lipid measures and PPARA genotype were observed in either whites or African Americans. Significant genotype-by-n-6 fatty acid intake interactions were observed only in whites for the 3'untranslated region (UTR) G-->A single nucleotide polymorphism (SNP) and total cholesterol (P = 0.03) and LDL cholesterol (P = 0.03). Significant genotype-by-long-chain n-3 fatty acid intake interactions were observed only in African Americans for the 3'UTR C-->T SNP and total cholesterol (P = 0.03) and LDL cholesterol (P = 0.02). CONCLUSIONS: Findings from the current study suggest that PPARA 3'UTR SNPs modulate the association between lipid concentrations and dietary n-6 fatty acid intake (in whites) and long-chain n-3 fatty acid intake (in African Americans) such that persons with homozygous variant genotypes have significantly lower total cholesterol and LDL-cholesterol measures when consuming higher quantities of n-6 or long-chain n-3 fatty acids.
BACKGROUND:Peroxisome proliferator-activated receptor-alpha (PPARA) regulates the expression of genes involved in lipid metabolism. The binding of polyunsaturated fatty acids (PUFAs) to PPARA results in rapid changes in the expression of genes involved in lipid oxidation, with long-chain n-3 fatty acids being potent activators of PPARA. OBJECTIVE: We evaluated the potential effect modification of PPARA genetic variation on the association between PUFA intake, specifically n-6 and long-chain n-3 fatty acid intakes, and multiple lipid measures in the large biethnic Atherosclerosis Risk in Communities (ARIC) Study. DESIGN: Study participants (10 134 whites and 3480 African Americans) were selected from the ARIC Study--a prospective investigation of atherosclerosis and its clinical sequelae. Multiple linear regression models were used to assess the relation between PPARA genotypes, as well as dietary fatty acid intake, and baseline lipid measures. PPARA-specific effects of variation were assessed by including genotype-by-fatty acid interaction terms in each statistical model. RESULTS:PPARA genotype frequencies were significantly different between whites and African Americans. No significant associations between lipid measures and PPARA genotype were observed in either whites or African Americans. Significant genotype-by-n-6fatty acid intake interactions were observed only in whites for the 3'untranslated region (UTR) G-->A single nucleotide polymorphism (SNP) and total cholesterol (P = 0.03) and LDL cholesterol (P = 0.03). Significant genotype-by-long-chain n-3 fatty acid intake interactions were observed only in African Americans for the 3'UTR C-->T SNP and total cholesterol (P = 0.03) and LDL cholesterol (P = 0.02). CONCLUSIONS: Findings from the current study suggest that PPARA 3'UTR SNPs modulate the association between lipid concentrations and dietary n-6fatty acid intake (in whites) and long-chain n-3 fatty acid intake (in African Americans) such that persons with homozygous variant genotypes have significantly lower total cholesterol and LDL-cholesterol measures when consuming higher quantities of n-6 or long-chain n-3 fatty acids.
Authors: A D White; A R Folsom; L E Chambless; A R Sharret; K Yang; D Conwill; M Higgins; O D Williams; H A Tyroler Journal: J Clin Epidemiol Date: 1996-02 Impact factor: 6.437
Authors: W D Rosamond; A R Folsom; L E Chambless; C H Wang; P G McGovern; G Howard; L S Copper; E Shahar Journal: Stroke Date: 1999-04 Impact factor: 7.914
Authors: W C Willett; L Sampson; M J Stampfer; B Rosner; C Bain; J Witschi; C H Hennekens; F E Speizer Journal: Am J Epidemiol Date: 1985-07 Impact factor: 4.897
Authors: Jane F Ferguson; Hooman Allayee; Robert E Gerszten; Folami Ideraabdullah; Penny M Kris-Etherton; José M Ordovás; Eric B Rimm; Thomas J Wang; Brian J Bennett Journal: Circ Cardiovasc Genet Date: 2016-04-19